These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 3556086)

  • 1. The significance of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine.
    Marsden CD; Jenner PG
    Ciba Found Symp; 1987; 126():239-56. PubMed ID: 3556086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The actions of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in animals as a model of Parkinson's disease.
    Jenner P; Marsden CD
    J Neural Transm Suppl; 1986; 20():11-39. PubMed ID: 3091760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Significance of the neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine for the etiology and therapy of idiopathic Parkinson disease].
    Lange KW
    Fortschr Neurol Psychiatr; 1989 Apr; 57(4):142-8. PubMed ID: 2656447
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MPTP: a pharmacological tool to study parkinsonism.
    Kulkarni SK; Mehta AK; Aley KO; Shukla VK
    Methods Find Exp Clin Pharmacol; 1986 Aug; 8(8):485-9. PubMed ID: 3489146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aging and 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced degeneration of dopaminergic neurons in the substantia nigra.
    Ricaurte GA; Irwin I; Forno LS; DeLanney LE; Langston E; Langston JW
    Brain Res; 1987 Feb; 403(1):43-51. PubMed ID: 3493827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An immunohistochemical study of the acute and long-term effects of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the marmoset.
    Waters CM; Hunt SP; Jenner P; Marsden CD
    Neuroscience; 1987 Dec; 23(3):1025-39. PubMed ID: 2893993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectivity of the parkinsonian neurotoxin MPTP: toxic metabolite MPP+ binds to neuromelanin.
    D'Amato RJ; Lipman ZP; Snyder SH
    Science; 1986 Feb; 231(4741):987-9. PubMed ID: 3080808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for neuromelanin involvement in MPTP-induced neurotoxicity.
    D'Amato RJ; Alexander GM; Schwartzman RJ; Kitt CA; Price DL; Snyder SH
    Nature; 1987 May 28-Jun 3; 327(6120):324-6. PubMed ID: 2884568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Histochemistry of MPTP oxidation in the rat brain: sites of synthesis of the parkinsonism-inducing toxin MPP+.
    Nakamura S; Vincent SR
    Neurosci Lett; 1986 Apr; 65(3):321-5. PubMed ID: 3487052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Does neuromelanin contribute to the vulnerability of catecholaminergic neurons in monkeys intoxicated with MPTP?
    Herrero MT; Hirsch EC; Kastner A; Ruberg M; Luquin MR; Laguna J; Javoy-Agid F; Obeso JA; Agid Y
    Neuroscience; 1993 Sep; 56(2):499-511. PubMed ID: 8247275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective retention of MPP+ within the monoaminergic systems of the primate brain following MPTP administration: an in vivo autoradiographic study.
    Herkenham M; Little MD; Bankiewicz K; Yang SC; Markey SP; Johannessen JN
    Neuroscience; 1991; 40(1):133-58. PubMed ID: 2052148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MPTP-induced parkinsonism in human and non-human primates--clinical and experimental aspects.
    Langston JW; Langston EB; Irwin I
    Acta Neurol Scand Suppl; 1984; 100():49-54. PubMed ID: 6333134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pargyline prevents MPTP-induced parkinsonism in primates.
    Langston JW; Irwin I; Langston EB; Forno LS
    Science; 1984 Sep; 225(4669):1480-2. PubMed ID: 6332378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MPTP toxicity: implications for research in Parkinson's disease.
    Kopin IJ; Markey SP
    Annu Rev Neurosci; 1988; 11():81-96. PubMed ID: 3129982
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neurotoxicity of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the monkey and man.
    Burns RS; Markey SP; Phillips JM; Chiueh CC
    Can J Neurol Sci; 1984 Feb; 11(1 Suppl):166-8. PubMed ID: 6608980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonian syndrome in Macaca fascicularis: which midbrain dopaminergic neurons are lost?
    German DC; Dubach M; Askari S; Speciale SG; Bowden DM
    Neuroscience; 1988 Jan; 24(1):161-74. PubMed ID: 3259295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MPTP: an industrial chemical and contaminant of illicit narcotics stimulates a new era in research on Parkinson's disease.
    Kopin IJ
    Environ Health Perspect; 1987 Nov; 75():45-51. PubMed ID: 3319563
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hemiparkinsonism in monkeys after unilateral caudate nucleus infusion of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP): behavior and histology.
    Imai H; Nakamura T; Endo K; Narabayashi H
    Brain Res; 1988 Dec; 474(2):327-32. PubMed ID: 3264746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The dopamine neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) produces histological lesions in the hypothalamus of the common marmoset.
    Gibb WR; Lees AJ; Jenner P; Marsden CD
    Neurosci Lett; 1986 Mar; 65(1):79-83. PubMed ID: 3486388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MPTP model of Parkinson's disease.
    Smeyne RJ; Jackson-Lewis V
    Brain Res Mol Brain Res; 2005 Mar; 134(1):57-66. PubMed ID: 15790530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.